Assessment Of Dutasteride (AVODART) In Extending The Time To Progression Of Low-Risk, Localized Prostate Cancer In Men
Status:
Completed
Trial end date:
2010-07-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to examine the effect of dutasteride on the inhibition of
low-risk, localized prostate cancer progression in men who would otherwise receive no active
therapy (expectant management).